Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.3699

+0.0199 (5.69%)

At close: Dec 24, 2025

Revenue by Product

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
ViraxClear and ViraxVet	156.42K	Log In	Log In	Log In
ViraxClear and ViraxVet Growth	1727.11%	Log In	Log In	Log In
ViraxClear and ViraxCare	-	Log In	Log In	Log In
Consulting	-	Log In	Log In	Log In
Consulting Growth	-	Log In	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
United Kingdom, Hong Kong, Singapore, China, British Virgin Islands	156.42K	Log In	Log In	Log In
United Kingdom, Hong Kong, Singapore, China, British Virgin Islands Growth	1727.11%	Log In	Log In	Log In
Singapore	-	Log In	Log In	Log In
British Virgin Island	-	Log In	Log In	Log In